Yield IPOs yielded disappointing returns while biotech performance was anemic.
13 companies were added to the IPO calendar - including 7 in the health care sector - making this an...read more
Viking Therapeutics, which is developing drugs to speed hip fracture recovery and treat various metabolic disorders, raised $24 million by offering 3 million shares at $8, within the range of $7 to $9. It previously expected to raise $20 million by offering 2.5...read more
US IPO Weekly Recap: 4 IPOs offer dividends and drugs
Yield IPOs yielded disappointing returns while biotech performance was anemic. 13 companies were added to the IPO calendar - including 7 in the health care sector - making this an...read more
What's hip in the IPO market: Viking Therapeutics prices upsized IPO at $8 midpoint
Viking Therapeutics, which is developing drugs to speed hip fracture recovery and treat various metabolic disorders, raised $24 million by offering 3 million shares at $8, within the range of $7 to $9. It previously expected to raise $20 million by offering 2.5...read more
Week ahead: 6 IPOs planned for the week of Apr 27
Up to six companies could price their IPOs this week. All are either LPs or health care companies (including three biotechs). ...read more
Week ahead: 3 IPOs planned for the week of April 20
This week the IPO market could see a high-yield REIT, a high-growth software provider and a small biotech. After strong performance from ...read more